Trial Profile
A Trial of Bioheart's Adipose-derived, Autologous Stem Cell Therapy (AdipoCell) in Combination With Muscle Derived, Autologous Stem Cell Therapy (MyoCell) for Congestive Heart Failure
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 05 Aug 2014
Price :
$35
*
At a glance
- Drugs Adipose-derived-autologous-stem-cell-therapy-U.S.-Stem-Cell (Primary) ; Muscle-derived autologous stem cell therapy Bioheart (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Sponsors Revita Life Sciences; U.S. Stem Cell
- 05 Aug 2014 New trial record